A case of congenital erythropietic porphyria
DOI:
https://doi.org/10.66344/jpad.v27i4.939Keywords:
Photosensitivity, Porphyria, Autosomal recessiveAbstract
Congenital erythropoietic porphyria (CEP) is a rare form of porphyria. It is an autosomal recessive disorder, which results from deficiency of enzyme uroporphyrinogen III cosynthase (or uroporphyrinogen III synthase). Due to the impaired function of this enzyme, excessive amounts of particular porphyrins accumulate, particularly in the bone marrow, plasma, red blood cells, urine, teeth, and bones. Due to photosensitivity, after exposure to light, the photo-activated porphyrins in the skin cause bullae (blistering) that often get infected. These infected lesions can lead to scarring, bone loss, and deformities. The hands, arms, and face are the most commonly affected areas. We report a 6-year-old male child presenting with CEP
References
1. Murphy GM. The cutaneous porphyrias: A review. The British Photodermatology Group. Br J Dermatol. 1999;140:573-81.
2. Fritsch C, Bolsen K, Ruzicka T, Goerz G. Congenital erythropoietic porphyria. J Am Acad Dermatol. 1997;36:594-610.
3. Bari A. Congenital erythropoietic porphyria in three siblings. Indian J Dermatol Venereol Leprol. 2007;73:340-2.
4. Koley S, Saoji V. Congenital erythropoietic porphyria: Two case reports. Indian J Dermatol. 2011;56:94-7.
5. Poh-Fitzpatric MB. Erythropoietic porphyrias: current mechanistic, diagnostic and therapeutic consideration. Semin Hematol. 1997;14:211.
6. Laorr A, Greenspan AA. Severe osteopenia in congenital erythropoietic porphyria. Can Assoc Radiol J. 1994;45: 307-9.
7. De AK, Das K, Sil A, Joardar S. A case of congenital erythropoietic porphyria without hemolysis. Indian J Dermatol. 2013;58:407.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Tulika Rai, Prakriti Shukla
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
